These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10851182)

  • 1. Biogenic amine transporters: regulation in flux.
    Blakely RD; Bauman AL
    Curr Opin Neurobiol; 2000 Jun; 10(3):328-36. PubMed ID: 10851182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system.
    Hoffman BJ; Hansson SR; Mezey E; Palkovits M
    Front Neuroendocrinol; 1998 Jul; 19(3):187-231. PubMed ID: 9665836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function and regulation of monoamine transporters: focus on the norepinephrine transporter.
    Apparsundaram S
    CNS Spectr; 2001 Aug; 6(8):671-4, 677-8. PubMed ID: 15520615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular analysis of vesicular amine transport.
    Liu Y; Peter D; Merickel A; Krantz D; Finn JP; Edwards RH
    Behav Brain Res; 1996; 73(1-2):51-8. PubMed ID: 8788477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters.
    Kocabas AM; Rudnick G; Kilic F
    J Neurochem; 2003 Jun; 85(6):1513-20. PubMed ID: 12787070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters.
    Vaughan RA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):1-7. PubMed ID: 15064332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    Wall SC; Gu H; Rudnick G
    Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental biogenic amine transporters: in vivo function, regulation and pathobiological significance.
    Nguyen TT; Tseng YT; McGonnigal B; Stabila JP; Worrell LA; Saha S; Padbury JF
    Placenta; 1999 Jan; 20(1):3-11. PubMed ID: 9950139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of glial monoamine transporters in the central nervous system].
    Inazu M; Takeda H; Matsumiya T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Aug; 23(4):171-8. PubMed ID: 13677912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacology of monoamine neurotransmitter transporters].
    Dohi T; Kitayama S; Kumagai K; Hashimoto W; Morita K
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(5):315-26. PubMed ID: 12491807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
    Xie Z; Westmoreland SV; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants and the monoamine masquerade.
    Sulzer D; Edwards RH
    Neuron; 2005 Apr; 46(1):1-2. PubMed ID: 15820686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychostimulants and monoamine transporters: upsetting the balance.
    Elliott JM; Beveridge TJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):94-100. PubMed ID: 15661632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing conformational changes in neurotransmitter transporters: a structural context.
    Goldberg NR; Beuming T; Soyer OS; Goldstein RA; Weinstein H; Javitch JA
    Eur J Pharmacol; 2003 Oct; 479(1-3):3-12. PubMed ID: 14612133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of dopamine quantal size in midbrain and hippocampal neurons.
    Pothos EN
    Behav Brain Res; 2002 Mar; 130(1-2):203-7. PubMed ID: 11864736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.
    Jayanthi LD; Ramamoorthy S
    AAPS J; 2005 Oct; 7(3):E728-38. PubMed ID: 16353949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors.
    Peter D; Jimenez J; Liu Y; Kim J; Edwards RH
    J Biol Chem; 1994 Mar; 269(10):7231-7. PubMed ID: 8125935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery.
    Ribeiro P; Patocka N
    Parasitol Int; 2013 Dec; 62(6):629-38. PubMed ID: 23800409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vesicular neurotransmitter transporters. Potential sites for the regulation of synaptic function.
    Varoqui H; Erickson JD
    Mol Neurobiol; 1997 Oct; 15(2):165-91. PubMed ID: 9396009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
    J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.